首页> 外文OA文献 >Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

【2h】

Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

机译：如89Zr-利妥昔单抗免疫PET所预测的，在CD20 + B细胞淋巴瘤中90Y-利妥昔单抗对放射免疫疗法的肿瘤靶向和放射剂量：未加标签的利妥昔单抗的预加载的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kristoff Muylle; Patrick Flamen; Danielle J. Vugts; Thomas Guiot; Ghanem Ghanem; Nathalie Meuleman; Pierre Bourgeois; Bruno Vanderlinden; Guus A. M. S. van Dongen; Hendrik Everaert; Mélanie Vaes; Dominique Bron;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab [J] . Kristoff Muylle, Patrick Flamen, Danielle J. Vugts, European Journal of Nuclear Medicine and Molecular Imaging . 2015,第8期

机译：如89Zr-利妥昔单抗免疫PET所预测的，在CD20 + B细胞淋巴瘤中90Y-利妥昔单抗对放射免疫疗法的肿瘤靶向和放射剂量：未加标签的利妥昔单抗的预加载的影响
2. Tumour targeting and radiation dose of radioimmunotherapy with Y-90-rituximab in CD20+B-cell lymphoma as predicted by Zr-89-rituximab immuno-PET: impact of preloading with unlabelled rituximab [J] . Muylle Kristoff, Flamen Patrick, Vugts Danielle J., European Journal of Nuclear Medicine and Molecular Imaging . 2015,第8期

机译：Zr-89-利妥昔单抗免疫PET预测，在CD20 + B细胞淋巴瘤中使用Y-90-利妥昔单抗在放射免疫疗法中的肿瘤靶向和放射剂量：未标记利妥昔单抗预加载的影响
3. Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy. [J] . Illidge TM, Bayne M, Brown NS, Blood: The Journal of the American Society of Hematology . 2009,第7期

机译：在低度B细胞淋巴瘤中分级（131）I-利妥昔单抗的1/2期研究：先前给予利妥昔单抗的剂量和肿瘤负荷对后续放射免疫治疗的影响。
4. FDG-PET/CT integration: impact on tumour localization and dose volume histograms in radiation therapy [C] . Caldwell, C.B., Mah, Engineering in Medicine and Biology Society, 2000. Proceedings of the 22nd Annual International Conference of the IEEE . 2000

机译：FDG-PET / CT整合：对放射治疗中的肿瘤定位和剂量体积直方图的影响
5. Targeting X-linked Inhibitor of Apoptosis Protein to Overcome Rituximab/Chemotherapy Resistance in B-Cell Lymphomas [D] . Khan, Sumera. 2019

机译：针对凋亡蛋白的X型抑制剂，克服B细胞淋巴瘤中的Rituximab /化疗抗性
6. Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab [O] . Kristoff Muylle, Patrick Flamen, Danielle J. Vugts, -1

机译：如89Zr-利妥昔单抗免疫PET所预测的在CD20 + B细胞淋巴瘤中90Y-利妥昔单抗对放射免疫疗法的肿瘤靶向和放射剂量：未加标签的利妥昔单抗的预加载的影响
7. Tumour targeting and radiation dose of radioimmunotherapy with ⁹⁰Y-rituximab in CD20+ B-cell lymphoma as predicted by ⁸⁹Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab [O] . Muylle, Kristoff, Flamen, Patrick, Vugts, Danielle, 2015

机译：^{89 Zr-利妥昔单抗免疫PET预测，^{90 Y-利妥昔单抗对CD20 + B细胞淋巴瘤放疗的肿瘤靶向和放射剂量：预加载未标记利妥昔单抗的影响}}

Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

著录项

相似文献

相关主题

期刊订阅